Conference

More Information

Therapeutic Antibodies Broshure
Book online today

Media Partners

Expert Review of Anti-infective Therapy provides expert reviews on therapeutics and diagnostics in the treatment of infectious disease. Coverage includes antibiotics, drug resistance, drug therapy, infectious disease medicine, antibacterial, antimicrobial, antifungal and antiviral approaches, and diagnostic tests.
  
Expert Review of Endocrinology and Metabolism provides extensive coverage of state-of-the-art research and clinical advancements in the field of endocrine control and metabolism, with a focus on screening, prevention, diagnostics, existing and novel therapeutics, as well as related molecular genetics, pathophysiology and epidemiology.
  
Expert Review of Molecular Diagnostics provides expert reviews on molecular diagnostic technologies and applied pharmacogenomics in clinical medicine. Coverage includes molecular diagnostics, biomarkers, diagnostic technologies, microarrays and biochips, proteomics, pharmacogenomics, pharmacogenetics and personalized medicine.
  
Future Virology delivers essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this ever-expanding area of research.
  


Bentham Science

Bentham Science Publishers is a major international STM publisher of high quality publications which publishes 93 print and online scholarly journals along with open access journals and e-books per year. Bentham Science journals have a large distribution and readership particularly in Europe, North America, Japan and Asia. Leading journals include Current Molecular Medicine (Impact Factor 5.254) and Current Medicinal Chemistry (Impact Factor 4.823):
  
 
  

Profile:

Every weekly issue of Cancer Drug News reports the important news on the companies, products, alliances and research that are shaping global cancer markets with regular sections on cancers affecting the brain, breast, GI tract, genito-urinary system, gynaecological system, blood and lung as well as melanoma/sarcoma.  For further information please visit: www.espicom.com/cdn

  

Profile:

Anti-Infective Drug News, published twice-monthly by Espicom Business Intelligence, reports the latest commercial developments in this high value product area.  A subscription delivers real commercial advantage and is the cost-effective, time-saving way to stay in touch with the market.  For further information and to subscribe today, visit www.espicom.com/ain

LinkedIn
LONZA
Quotient Bio Research
http://www.pall.com/
http://www.px-therapeutics.com/
Quality Assistance
Genscript